Nation

AstraZeneca seeks US authorization for COVID-19 vaccine

By Tanvi Sabharwal

Drugmaker AstraZeneca may file for emergency authorization of its coronavirus vaccine, for use in the United States.

The company is seeking US approval by the end of March or early April, if succeeded 30 million doses are ready to be distributed.

“We expect data from our US Phase III trial to be available soon, in the coming weeks, and we plan to file for emergency use authorization shortly thereafter,” a company spokesperson has stated.

The vaccine, which was administered in EU, has been halted for use over concerns about blood clots found in some recipients.

US citizens are currently being administered vaccines produced by Pfizer, Moderna, and Johnson & Johnson.

Tags: AstraZeneca AstraZeneca vaccine Covid vaccine Johnson & Johnson Moderna Pfizer United States

Tanvi Sabharwal

Tanvi Sabharwal is a graduate in Economics with experience in marketing and strategy. A media enthusiast, she has a deep-rooted interest in social policy and development. Tanvi is currently working as a Business and Current Affairs reporter at USAnewshour.com and can be reached at tanvi.sabharwal21@gmail.com